The use of partial splenic artery embolization made it possible to administer interferon and ribavirin therapy in a liver transplant patient with fibrosing cholestatic hepatitis C complicated with thrombocytopenia.
Sohara
Naondo
N
Takagi
Hitoshi
H
Kakizaki
Satoru
S
Sato
Ken
K
Mori
Masatomo
M
D000998:Antiviral Agents / Q000627:therapeutic use; D002779:Cholestasis / Q000150:complications*; D004621:Embolization, Therapeutic / Q000379:methods*; D005260:Female; D006526:Hepatitis C / Q000150:complications* / Q000628:therapy*; D006801:Humans; D007372:Interferons / Q000627:therapeutic use*; D016031:Liver Transplantation / Q000009:adverse effects* / Q000379:methods*; D008875:Middle Aged; D012254:Ribavirin / Q000494:pharmacology*; D013156:Splenectomy; D013157:Splenic Artery / Q000473:pathology*; D013921:Thrombocytopenia / Q000150:complications* / Q000628:therapy
D000998:Antiviral Agents; D012254:Ribavirin; D007372:Interferons